Health
Moffitt researchers discover regulatory pathway that blocks immune response against cancer – EurekAlert
In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby…
TAMPA, Fla. – A hallmark of cancer is its ability to evade the immune system. It is why researchers are focused on finding new strategies and targets to jumpstart the immune system so it can mount a response against tumors. One such target is the inhibitory receptor T-cell immunoglobulin and mucin domain 3 (TIM-3), a protein that is overexpressed in many different types of cancer and is associated with poor patient outcomes. It is known to block the activity of immune cells, such as dendritic cells,…
-
General12 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News15 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General14 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
Noosa News22 hours agoBrisbane muralist explains why he ended his plan to eat one chicken a day for a year